Ernexa Therapeutics Inc (ERNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 3,259 | 2,586 | 3,378 | 5,686 | 3,223 |
| Receivables | 1,195 | 1,143 | 714 | 928 | 919 |
| Other current assets | 1,090 | 2,539 | 4,866 | 2,998 | 3,990 |
| TOTAL | $6,070 | $6,785 | $9,638 | $10,662 | $9,110 |
| Non-Current Assets | |||||
| PPE Net | 2,822 | 4,667 | 3,678 | 3,101 | 3,915 |
| Intangibles | 696 | 667 | 1,004 | 966 | 988 |
| Other Non-Current Assets | 4,537 | 2,745 | 2,250 | 1,966 | 2,395 |
| TOTAL | $8,055 | $8,079 | $6,932 | $6,033 | $7,298 |
| Total Assets | $14,125 | $14,864 | $16,570 | $16,695 | $16,408 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 2,739 | 1,000 | 5,059 | 2,988 | 1,072 |
| Accounts payable and accrued liabilities | 835 | 271 | 390 | 247 | 211 |
| Accrued Expenses | 1,078 | 1,016 | 1,064 | 1,757 | 1,694 |
| Other current liabilities | 419 | 337 | 192 | 291 | 639 |
| TOTAL | $6,095 | $4,024 | $10,747 | $6,643 | $5,122 |
| Non-Current Liabilities | |||||
| Long Term Debt | 0 | 2,729 | 8 | 5,123 | 6,366 |
| Deferred Revenues | 460 | 1,267 | 3,746 | 1,059 | 1,214 |
| Other Non-Current Liabilities | 2,917 | 0 | 52 | 12 | 0 |
| TOTAL | $2,939 | $3,923 | $287 | $5,984 | $7,438 |
| Total Liabilities | $9,034 | $7,947 | $11,034 | $12,627 | $12,560 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 5 | 5 | 4 | 4 | 3 |
| Common Shares | 14 | 14 | 13 | 11 | 9 |
| Retained earnings | -131,457 | -129,394 | -129,119 | -128,026 | -125,087 |
| Other shareholders' equity | -187 | -255 | -110 | -232 | -283 |
| TOTAL | $5,091 | $6,917 | $5,536 | $4,068 | $3,848 |
| Total Liabilities And Equity | $14,125 | $14,864 | $16,570 | $16,695 | $16,408 |